Replies to post #151744 on Biotech Values

[genisi]

Point about age and new anti coagulation agents

Since the majority of atrial fib patients are over 70 and therefore are at risk for renal dysfunction, Eliquis will have an advantage as it has lower renal excretion percentage than both Pradaxa and Xarelto.